Posters & Abstracts

Mirvie is conducting ongoing clinical research to validate existing peer-reviewed evidence, enhance the platform's performance, and improve the understanding of other pregnancy complications.

Prospective validation of USPSTF guidelines for preeclampsia prediction and clinician compliance with aspirin recommendations
USPSTF’s moderate risk factors for preeclampsia — high BMI, advanced maternal age, and Black race* — are weakly predictive, have limited association with aspirin prophylaxis, and are widely prevalent.
Mirvie SMFM 2025 Poster
Predicts majority of severely small-for-gestational-age infants using a novel cell-free RNA model independent of preeclampsia, chronic hypertension and diabetes status.
Prediction of severely small-for-gestational-age infants using a novel cell-free RNA model
Mirvie SMFM 2025 Poster
Cell-free RNA detection of “placental” and immunologic differentially-expressed genes in healthy pregnant vs. non-pregnant individuals
Cell-free RNA offers a comprehensive way to track physiological changes in pregnancy, but use caution with gene annotations.
Mirive Woman's Hospital, Precia Group, ACOG Poster Abstract
Main Street, USA Enrollment: Community hospital recruitment strategies for diverse and equitable selection of pregnant participants in a prospective cohort study
Patients at community hospitals can and should be included in clinical research for better representation.
Mirive Woman's Hospital, Precia Group, ACOG Poster Abstract
Decentralized clinical trials: A flexible and efficient adjunct to accelerate pregnancy complication research
Mobile-friendly virtual recruitment accelerates pregnancy health research.
Mirive ACOG Poster Abstract
RNA profiles reveal patterens of circadian rhythm in pregnancy
Cell-free RNA captures daily biological rhythm in pregnancy
Mirive SMFM Poster Abstract